Initial data of patients included in the independent casecontrol study for the analysis of the association of MRP3 expression and prednisone response
. | Poor response to prednisone . | Good response to prednisone . |
|---|---|---|
| Number of patients | 20 | 20 |
| Sex | ||
| Female | 10 | 10 |
| Male | 10 | 10 |
| Age, y | ||
| Younger than 1 | 0 | 0 |
| Older than 1; less than 10 | 12 | 12 |
| Older than 10 | 8 | 8 |
| Initial WBC count, 109/L | ||
| Less than 10 | 4 | 4 |
| More than 10; less than 50 | 6 | 6 |
| More than 50; less than 100 | 5 | 5 |
| More than 100 | 5 | 5 |
| Immunophenotype | ||
| T-ALL | 10 | 10 |
| Common ALL | 10 | 10 |
| MRP3, median (range) | 0.00022 (0-0.0033) | 0.00023 (0-0.0052) |
. | Poor response to prednisone . | Good response to prednisone . |
|---|---|---|
| Number of patients | 20 | 20 |
| Sex | ||
| Female | 10 | 10 |
| Male | 10 | 10 |
| Age, y | ||
| Younger than 1 | 0 | 0 |
| Older than 1; less than 10 | 12 | 12 |
| Older than 10 | 8 | 8 |
| Initial WBC count, 109/L | ||
| Less than 10 | 4 | 4 |
| More than 10; less than 50 | 6 | 6 |
| More than 50; less than 100 | 5 | 5 |
| More than 100 | 5 | 5 |
| Immunophenotype | ||
| T-ALL | 10 | 10 |
| Common ALL | 10 | 10 |
| MRP3, median (range) | 0.00022 (0-0.0033) | 0.00023 (0-0.0052) |
Cases and controls were matched for age, sex, immunophenotype, and initial WBC count. All samples were negative for BCR/ABL, TEL/AML 1, and MLL/AF4 rearrangements.